These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 32975448

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of acetazolamide on pulmonary artery pressure and prevention of high-altitude pulmonary edema after rapid active ascent to 4,559 m.
    Berger MM, Sareban M, Schiefer LM, Swenson KE, Treff F, Schäfer L, Schmidt P, Schimke MM, Paar M, Niebauer J, Cogo A, Kriemler S, Schwery S, Pickerodt PA, Mayer B, Bärtsch P, Swenson ER.
    J Appl Physiol (1985); 2022 Jun 01; 132(6):1361-1369. PubMed ID: 35511718
    [Abstract] [Full Text] [Related]

  • 3. Day of Ascent Dosing of Acetazolamide for Prevention of Acute Mountain Sickness.
    Lipman GS, Jurkiewicz C, Winstead-Derlega C, Navlyt A, Burns P, Walker A, Phillips C, Reilly A, Burnier A, Romero J, Warner K, Hackett P.
    High Alt Med Biol; 2019 Sep 01; 20(3):271-278. PubMed ID: 31259608
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Reappraisal of acetazolamide for the prevention of acute mountain sickness: a systematic review and meta-analysis.
    Kayser B, Dumont L, Lysakowski C, Combescure C, Haller G, Tramèr MR.
    High Alt Med Biol; 2012 Jun 01; 13(2):82-92. PubMed ID: 22724610
    [Abstract] [Full Text] [Related]

  • 7. Findings of Cognitive Impairment at High Altitude: Relationships to Acetazolamide Use and Acute Mountain Sickness.
    Phillips L, Basnyat B, Chang Y, Swenson ER, Harris NS.
    High Alt Med Biol; 2017 Jun 01; 18(2):121-127. PubMed ID: 28509579
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial.
    Chow T, Browne V, Heileson HL, Wallace D, Anholm J, Green SM.
    Arch Intern Med; 2005 Feb 14; 165(3):296-301. PubMed ID: 15710792
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A Randomized Controlled Trial of the Lowest Effective Dose of Acetazolamide for Acute Mountain Sickness Prevention.
    Lipman GS, Jurkiewicz C, Burnier A, Marvel J, Phillips C, Lowry C, Hawkins J, Navlyt A, Swenson ER.
    Am J Med; 2020 Dec 14; 133(12):e706-e715. PubMed ID: 32479750
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial.
    Basnyat B, Gertsch JH, Holck PS, Johnson EW, Luks AM, Donham BP, Fleischman RJ, Gowder DW, Hawksworth JS, Jensen BT, Kleiman RJ, Loveridge AH, Lundeen EB, Newman SL, Noboa JA, Miegs DP, O'Beirne KA, Philpot KB, Schultz MN, Valente MC, Wiebers MR, Swenson ER.
    High Alt Med Biol; 2006 Dec 14; 7(1):17-27. PubMed ID: 16544963
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Acute mountain sickness prophylaxis: a high-altitude perspective.
    DeLellis SM, Anderson SE, Lynch JH, Kratz K.
    Curr Sports Med Rep; 2013 Dec 14; 12(2):110-4. PubMed ID: 23478562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.